COVI-19 IMMUNITY SHIELD Trademark

Trademark Overview


On Thursday, July 16, 2020, a trademark application was filed for COVI-19 IMMUNITY SHIELD with the United States Patent and Trademark Office. The USPTO has given the COVI-19 IMMUNITY SHIELD trademark a serial number of 90056588. The federal status of this trademark filing is ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE as of Tuesday, April 13, 2021. This trademark is owned by COVImmune Pharma LLC. The COVI-19 IMMUNITY SHIELD trademark is filed in the Pharmaceutical Products and Medical & Beauty Services & Agricultural Services categories with the following description:

Pharmaceutical preparations for the treatment of immunological, viral, inflammatory, infectious autoimmune disorders; Pharmaceutical preparations for the treatment and prevention of COVID-19 (SARSCOV-2) and coronavirus; Pharmaceutical preparations and substances, used internally as liquid medicines syrup, emulsion or suspension or solids as pills or capsules or chewable tablets for the treatment and prevention of viral infections by boosting the immune system to kill viruses, bacteria, coronaviruses including COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations for the prevention of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations for the treatment and prevention of COVID-19 (SARSCOV-2) and coronavirus; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations for COVID-19 (SARSCOV-2) and coronavirus; Pharmaceutical preparations...

Dispensing of pharmaceuticals; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; pharmaceutical advice
covi-19 immunity shield

General Information


Serial Number90056588
Word MarkCOVI-19 IMMUNITY SHIELD
Filing DateThursday, July 16, 2020
Status602 - ABANDONED - FAILURE TO RESPOND OR LATE RESPONSE
Status DateTuesday, April 13, 2021
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesPharmaceutical preparations for the treatment of immunological, viral, inflammatory, infectious autoimmune disorders; Pharmaceutical preparations for the treatment and prevention of COVID-19 (SARSCOV-2) and coronavirus; Pharmaceutical preparations and substances, used internally as liquid medicines syrup, emulsion or suspension or solids as pills or capsules or chewable tablets for the treatment and prevention of viral infections by boosting the immune system to kill viruses, bacteria, coronaviruses including COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations for the prevention of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations for the treatment and prevention of COVID-19 (SARSCOV-2) and coronavirus; Pharmaceutical preparations for the treatment of infectious diseases; Pharmaceutical preparations for the treatment of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations for COVID-19 (SARSCOV-2) and coronavirus; Pharmaceutical preparations, namely, elixirs for the treatment of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical products for treating respiratory diseases; Chemical preparations for pharmaceutical or medical purposes, namely, for COVID-19 (SARS-COV-2) and coronavirus; Inhaled pharmaceutical preparations for the treatment of COVID-19 or coronavirus respiratory diseases and disorders; Therapeutic pharmaceutical for the treatment of COVID-19 (SARS-COV-2) and coronavirus; Pharmaceutical preparations to boost, enhance, induce, or train and educate the immune system for the treatment of COVID-19 disease and immune system related diseases and disorders Dietary and nutritional supplements for therapeutic treatment to boost immune system responses against COVID-19 disease and immune related diseases and disorders; Dietary and nutritional supplements for boosting immune system responses; Pharmaceuticals, namely, immunomodulators, antivirals, antibiotics and anti-inflammatories
Goods and ServicesDispensing of pharmaceuticals; Providing information relating to diagnostic, prophylactic and therapeutic properties of pharmaceuticals; pharmaceutical advice
Pseudo MarkCOVID ONE NINE IMMUNITY SHIELD; COVID NINETEEN IMMUNITY SHIELD

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateThursday, August 13, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, August 13, 2020
Primary Code044
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameCOVImmune Pharma LLC
Party Type10 - Original Applicant
Legal Entity Type16 - Limited Liability Company
AddressLynnwood, WA 98046

Trademark Events


Event DateEvent Description
Tuesday, April 13, 2021ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Tuesday, April 13, 2021ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Wednesday, September 30, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Wednesday, September 30, 2020NON-FINAL ACTION E-MAILED
Wednesday, September 30, 2020NON-FINAL ACTION WRITTEN
Tuesday, September 29, 2020ASSIGNED TO EXAMINER
Thursday, August 13, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED IN TRAM
Monday, July 20, 2020NEW APPLICATION ENTERED IN TRAM